Close menu




 

Stefan Feulner

  • E-Commerce
  • Fintech
  • Blockchain
  • AI

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.

Before founding his own company, he held various positions as business editor, fund advisor, portfolio manager and finally as CEO of a listed investment company. He also held several positions on the supervisory board.

He is passionate about analyzing a wide variety of business models and investigating new trends, especially in the areas of e-commerce, fintech, blockchain or artificial intelligence.


Commented by Stefan Feulner

Commented by Stefan Feulner on May 22nd, 2024 | 07:00 CEST

BioNTech, Cardiol Therapeutics, Morphosys - On the verge of a breakout

  • Biotechnology
  • Pharma

Compared to the broader indices, DAX and Dow Jones, which have already reached new all-time highs, the Nasdaq Biotech Index is currently lagging. The sector index is still around 23% below its peak from August 2021. Nevertheless, the sector is on the move. In addition to takeovers, which have increased dramatically in 2024, many companies have important study results in the pipeline that could kick-start a rally.

Read

Commented by Stefan Feulner on May 21st, 2024 | 07:00 CEST

Lynas, Almonty Industries, General Motors - Is the trade war escalating, and what is Tesla doing?

  • Mining
  • Tungsten
  • Electromobility
  • RareEarths

The stock markets continue their record-breaking run. The Dow Jones Industrial has climbed to the 40,000-point mark for the first time in its history, and the DAX is also on the verge of breaking through the 19,000-point barrier. So far, so good, one might say. However, something is brewing in the background with regard to the trade war between the US and China, which could put enormous pressure on company margins in the future. As a result, critical commodities, in particular, are likely to be on the verge of a strong upward impulse.

Read

Commented by Stefan Feulner on May 14th, 2024 | 07:30 CEST

Bayer, Defence Therapeutics, Novavax - Major events

  • Biotechnology
  • Pharma

The biotechnology sector is still on the move and is currently characterized by a high degree of volatility. For instance, BioNTech, a former star during the pandemic, reported a net loss of EUR 315 million in the first quarter. The Mainz-based biotech now wants to focus more on the development of its cancer drugs due to the slump in demand for COVID-19 vaccines. However, for years, innovative, undiscovered companies have existed in this billion-dollar market that could, with their technologies, become the new high-flyers in the biotech industry.

Read

Commented by Stefan Feulner on May 13th, 2024 | 06:30 CEST

Rheinmetall, Power Nickel, Bloom Energy - Will the rally continue?

  • Mining
  • Gold
  • Lithium
  • Commodities
  • Defense

After a brief pause in recent weeks, the rally in Germany's leading index, the DAX, has continued unabated, with the target of 19,000 points already in sight. Defense stocks remain the undisputed top performers. Another sector that has taken center stage in recent weeks is commodities. In addition to gold, silver and copper, the industrial metals lithium and nickel are also forming solid foundations for the next upward impulse. Corresponding companies were already running ahead of the base value.

Read

Commented by Stefan Feulner on May 6th, 2024 | 07:00 CEST

Canopy Growth, Globex Mining and Rock Tech Lithium with strong signals

  • Mining
  • Gold
  • Silver
  • Cannabis
  • Lithium

Now that the precious metals gold and silver are taking a breather after a rally, other markets are becoming the focus of investor interest. In addition to copper, which is likely to reach new highs in the medium term due to supply shortages, lithium, an industrial metal essential for electromobility, continues to work on bottoming out. However, the highlight of the past week in terms of volatility was cannabis stocks, which are expected to remain in focus in the coming weeks.

Read

Commented by Stefan Feulner on April 29th, 2024 | 07:15 CEST

Newmont, Royal Helium, Anglo American - Commodities on the rise

  • Mining
  • Helium
  • Commodities
  • Gold

Precious metals remain in demand due to geopolitical uncertainties. After gold moved away from its highs above the USD 2,400 per ounce mark, there were no further major sell-offs. Industrial metals are also still in vogue. Copper has risen by around 20% since the beginning of the year and posted a new high for the year, while nickel has moved well away from its lows for the year. On the other hand, the noble gas helium, for which a global undersupply is predicted due to rising demand from the defense industry, has seen little movement.

Read

Commented by Stefan Feulner on April 23rd, 2024 | 07:30 CEST

Plug Power, Carbon Done Right Developments, Nel ASA - Exponential growth

  • CarbonCredits
  • Sustainability
  • renewableenergies

In recent months, geopolitical uncertainties have increased with escalations in the Gaza Strip and the ongoing conflict in Ukraine, dominating the headlines in newspapers and news portals. As a result, reporting on climate change has taken a back seat somewhat. Nevertheless, it remains one of the most significant challenges in human history. Due to global warming, extreme weather events and natural disasters are increasing noticeably. In addition to the expansion of renewable energies, the introduction of emissions certificates is considered an effective means of promoting climate protection.

Read

Commented by Stefan Feulner on April 22nd, 2024 | 07:30 CEST

After Gold and Silver: Nickel on the Move! Kinross Gold, Power Nickel, Royal Gold

  • Mining
  • Gold
  • Silver
  • Nickel

The geopolitical uncertainties with the escalation between Iran and Israel helped precious metals to further price surges. Despite being technically overbought, gold was able to hold its ground near the USD 2,400 per ounce mark, while silver closed the week with a further gain of around 3%. In the shadow of this, industrial metals are moving into the spotlight after a weak overall year in 2023. Alongside copper, nickel, an important raw material for many low-carbon technologies, has established a solid base in recent months.

Read

Commented by Stefan Feulner on April 16th, 2024 | 07:40 CEST

Formycon, Defence Therapeutics, Morphosys - Significant movement in the biotech sector

  • Biotechnology
  • Pharma
  • Cancer

At the moment, investors are focusing on gold and Bitcoin in addition to the most important indices, like the DAX and Dow Jones. Meanwhile, the biotechnology sector is barely mentioned in the local newspapers. However, the market is on the move, and the wave of takeovers continues unabated. Recently, the Danish pharmaceutical company Genmab announced it was acquiring the private biotech company ProfoundBio for USD 1.8 billion in cash. The acquisition is intended to help deepen the cancer pipeline with next-generation antibody-drug conjugate therapies. Big Pharma is likely to make further acquisitions in this area in the near future.

Read

Commented by Stefan Feulner on April 15th, 2024 | 06:45 CEST

First Majestic Silver, Desert Gold, Albemarle - Escalation paves the way

  • Mining
  • Gold
  • Silver
  • chemicals
  • Lithium

The events at the weekend, during which Iran carried out a massive airstrike on Israel for the first time, are likely to have escalated the already troubled geopolitics to a new level. It is not yet known whether Israel is planning a counter-attack. Precious metals gold and silver are once again likely to benefit from the uncertainties following the rather weak close to the week. The yellow precious metal could recapture the USD 2,400 per ounce mark, which could also boost the shares of producers and gold exploration companies.

Read